Management of Moderate-Severe Proximal LCx Stenosis with High Calcium Score

Diagnostic Considerations

The American College of Radiology recommends invasive coronary angiography (ICA) with functional assessment (FFR/iFR) to confirm the 70% proximal LCx stenosis and determine hemodynamic significance, followed by consideration of revascularization if the lesion is flow-limiting 1
The patient's CAD-RADS classification is 3-4A/3, which represents moderate-to-severe obstructive disease requiring urgent evaluation, according to the American College of Cardiology 2, 1
A calcium score of 461 places the patient at the 94th percentile, indicating substantial atherosclerotic burden and significantly elevated cardiovascular risk, as stated by the American College of Cardiology 3

The American College of Radiology recommends proceeding directly to ICA with FFR or iFR measurement for patients with 70% proximal LCx stenosis, as this meets criteria for CAD-RADS 4A (severe single-vessel disease 70-99%) 1
If FFR ≤0.80 or iFR ≤0.89, the American College of Cardiology recommends proceeding with revascularization, with percutaneous coronary intervention (PCI) with drug-eluting stent as the preferred approach for isolated proximal LCx disease 1, 4
The American College of Cardiology recommends considering coronary artery bypass grafting (CABG) only if anatomy is unfavorable for PCI or if additional high-grade disease is discovered during angiography 4

The American College of Cardiology recommends initiating high-intensity statin therapy, such as atorvastatin 80 mg daily or rosuvastatin 40 mg daily, to achieve LDL-C <70 mg/dL (ideally <55 mg/dL) 5
The American College of Cardiology recommends aspirin 81 mg daily indefinitely, and adding a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) for minimum 12 months if PCI is performed 5, 4
The American College of Cardiology recommends aggressive risk factor modification, including smoking cessation, diabetes control (HbA1c <7%), and blood pressure <130/80 mmHg 5

The American College of Radiology recommends avoiding stress testing (SPECT, stress echo, exercise treadmill) as the next step in patients with 70% stenosis and soft plaque, as functional testing adds delay without providing the anatomic detail needed for revascularization planning 1, 6
The American Heart Association recommends not dismissing the calcium score as "just a number", as a calcium score >400 is associated with screening for clinically silent ischemia, and this patient's score of 461 predicts significantly elevated annual cardiovascular event rates 3

The American College of Cardiology recommends repeat functional testing (stress test or stress imaging) at 6-12 months to assess for restenosis or progression of disease in other territories, and annual cardiovascular risk assessment with lipid panel, blood pressure monitoring, and medication adherence review 4, 5